Pluri Inc. Form NT 10-Q: Notification of late filing: quarterly report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2007-05-15: Form NT 10-Q; Period of report 2007-03-31; Description FORM NT; Document formnt.htm.
- 2005-02-14: Form NT 10-Q; Period of report 2004-12-31; Description FORM NT; Document formntf10qsb123104.htm.
- 2004-05-17: Form NT 10-Q; Period of report 2004-03-31; Description FORM 12B-25; Document f12b2503312004.htm.
- 2003-11-14: Form NT 10-Q; Period of report 2003-09-30; Description Notification of late filing: quarterly report; Document f12b25.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2007-05-15 | NT 10-Q | 2007-03-31 | FORM NT | formnt.htm |
| 2005-02-14 | NT 10-Q | 2004-12-31 | FORM NT | formntf10qsb123104.htm |
| 2004-05-17 | NT 10-Q | 2004-03-31 | FORM 12B-25 | f12b2503312004.htm |
| 2003-11-14 | NT 10-Q | 2003-09-30 | Notification of late filing: quarterly report | f12b25.htm |
| 2003-05-15 | NT 10-Q | 2003-03-31 | Notification of late filing: quarterly report | f12b25.htm |
| 2002-11-15 | NT 10-Q | 2002-09-30 | Notification of late filing: quarterly report | form1225-1114.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |